Logo
Sound journalism, grounded in facts and Biblical truth | Donate

Agencies recommend pausing Johnson & Johnson vaccine


A vaccination site at a shopping mall in Los Angeles Associated Press/Photo by Damian Dovarganes (file)

Agencies recommend pausing Johnson & Johnson vaccine

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration on Tuesday said they were investigating potentially dangerous blood clots in six women who received the single-dose COVID-19 vaccine. In the meantime, they recommended the country pause use of the shot. The reported complications appeared in women within two weeks of vaccination, and they also had low platelets in veins that drain blood from the brain. Federal officials want time to investigate and educate doctors on spotting and treating the clots. A CDC advisory committee plans to meet on Wednesday to discuss the cases.

Do other vaccines have similar problems? The blood clots are similar to those that European authorities said AstraZeneca’s COVID-19 vaccine may cause. Johnson & Johnson and AstraZeneca’s shots use an adenovirus to carry a protein that causes the body to make coronavirus antibodies, while the two leading vaccines used in the United States—from Pfizer-BioNTech and Moderna—use mRNA technology.

Dig deeper: Read Leah Hickman’s report in Vitals explaining how much different vaccines relied on aborted fetal cell lines.


Charissa Koh

Charissa is a WORLD reporter who often writes about poverty-fighting and criminal justice. She resides with her family in Atlanta.

@CharissaKoh

COMMENT BELOW

Please wait while we load the latest comments...

Comments

Please register, subscribe, or login to comment on this article.